Ajanta Pharma informs about updates

21 Jan 2022 Evaluate
Ajanta Pharma has informed that the Company is undertaking the Buyback in accordance with the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (the 'Buyback Regulations') and the Companies Act, 2013, as amended. The Company enclosed the soft copy (in pdf version) of the letter of offer dated 19th January 2022 of the Company in relation to the Buyback Offer ('Letter of Offer') for information and records. The Buy-back offer will open on Thursday, February 03, 2022 and will close on Wednesday, February 16, 2022. All terms used herein and not specifically defined shall have the same meaning as ascribed to such terms under the Letter of Offer.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2767.65 -67.05 (-2.37%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×